Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Dose Addition of Tramadol to Levobupivacaine Femoral Nerve Block Prolong Its Analgesic Efficacy in Patients Undergoing Anterior Cruciate Ligament Reconstruction?

Doaa Rashwan.




Abstract

This study was designed to evaluate the effect of addition of tramadol to levobupivacaine femoral nerve block in patients undergoing anterior cruciate ligament reconstruction under general anaesthesia. 60 male patients ASA I-II aged 18-45 years, scheduled for anterior cruciate ligament reconstruction under general anaesthesia, patients were randomly allocated into two equal sized groups using closed envelope technique: Group L: (n= 30) femoral nerve block with levobupivacaine (0.5%) 20ml. Group LT: (n= 30) femoral nerve block with levobupivacaine (0.5%) 20ml +2mg/kg tramadol. Time to first request of postoperative analgesia, severity of postoperative pain at rest using VAS, dose of pethidine consumed in 24 h were recorded. There were no statistical significant differences between the two studied groups as regard to patient characteristics, time to first request of postoperative analgesia, postoperative pethidine consumption and 24 hours VAS at rest between the two studied group. The addition of tramadol 2mg/kg did not improve postoperative analgesic efficacy of levobupivacaine (0.5%) femoral nerve block in patients undergoing anterior cruciate ligament reconstruction under general anaesthesia.

Key words: Femoral nerve block, levobupivacaine, tramadol, knee surgery






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.